COMPASS Pathways plc SEC filings CMPS

COMPASS Pathways plc has 344 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

COMPASS Pathways plc SEC filings
Form Description Filed Period
EFFECT Filing May 7, 2025 —
CORRESP Letter to the SEC May 5, 2025 —
UPLOAD Letter from the SEC Mar 6, 2025 —
EFFECT Filing Oct 17, 2024 —
CORRESP Letter to the SEC Oct 15, 2024 —
UPLOAD Letter from the SEC Oct 11, 2024 —
EFFECT Filing Sep 18, 2023 —
CORRESP Letter to the SEC Sep 14, 2023 —
UPLOAD Letter from the SEC Sep 14, 2023 —
EFFECT Filing May 3, 2022 —
POSASR Filing Feb 24, 2022 —
EFFECT Filing Apr 29, 2021 —
CORRESP Letter to the SEC Apr 27, 2021 —
CORRESP Letter to the SEC Apr 27, 2021 —
UPLOAD Letter from the SEC Mar 8, 2021 —
DRS Filing Mar 4, 2021 —
EFFECT Filing Sep 17, 2020 —
EFFECT Filing Sep 17, 2020 —
CERT 8a cert Sep 17, 2020 —
8-A12B Filing Sep 15, 2020 —
CORRESP Letter to the SEC Sep 15, 2020 —
CORRESP Letter to the SEC Sep 15, 2020 —
CORRESP Letter to the SEC Sep 9, 2020 —
UPLOAD Letter from the SEC Sep 8, 2020 —
CORRESP Letter to the SEC Sep 2, 2020 —
DRSLTR Filing Aug 10, 2020 —
DRS/A Filing Aug 10, 2020 —
UPLOAD Letter from the SEC Jul 31, 2020 —
DRS Filing Jul 2, 2020 —

Showing 29 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CMPS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Chesire, United Kingdom
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1816590
Former names
Compass Rx Ltd. (until Aug 10, 2020)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.